ELK1 and urinary bladder cancer: DHT increased ELK1 gene expression in two AR-positive bladder cancer sublines, UMUC3-control-shRNA (3.4-fold) and 647V-AR (3.2-fold), but not in AR-negative sublines (Figure 3A).